Lupus nephritis and end-stage kidney disease

American Journal of the Medical Sciences

Volumn 346, Issue 4, 2013, Pages 319-323

  Maroz, Natallia ^a   Segal, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

End stage kidney disease; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

DIALYSIS; DISEASE SEVERITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MORBIDITY; MORTALITY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WORLD HEALTH ORGANIZATION;

EID: 84885018204     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31827f4ee3     Document Type: Review

References (45)

1. Bertsias GK, Boumpas DT. Lupus nephritis-winning a few battles but not the war. Nat Rev Rheumatol 2011;7:441-2
2. Osler W. On the visceral manifestations of the erythema group of skin diseases. Am J Med Sci 1904;127:1-23
3. Muehrcke R, Kark R, Pirani C, et al. Histological and clinical evolution of lupus nephritis. Ann Rheum Dis 1955;14:371-7
4. Fiehn C. Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure. J Rheumatol 2006;33:1464-6 (Pubitemid 44168811)
5. Cervera R, Khamashta M, Hughes G. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009;18: 869-74
6. Cervera R, Khamashta MA, Font J, et al; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308 (Pubitemid 37229465)
7. Jarrett M, Santhanam S, Del Greco F. The clinical course of endstage renal disease in systemic lupus erythematosus. Arch Intern Med 1983;143:1353-6 (Pubitemid 13067915)
8. Mojcik C, Klippel J. End-stage renal disease and systemic lupus erythematosus. Am J Med 1996;101:100-7 (Pubitemid 26285947)
9. Sule S, Fivush B, Neu A, et al. Increased hospitalizations and death in patients with ESRD secondary to lupus. Lupus 2012;21:1208-13
10. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 2000;160:3136-40
11. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis in the United States, 1996-2004. J Rheumatol 2009;36:63-7
12. Costenbader K, Desai A, Alarcon G, et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum 2011;63:1681-8
13. Hiraki L, Lu B, Alexander S, et al. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum 2011;63:1988-97
14. Bartosh SM, Fine RN, Sullivan EK. Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American pediatric renal transplant cooperative study. Transplantation 2001;72:973-8 (Pubitemid 32879884)
15. Pereira T, Abitbol C, Seeherunvong W, et al. Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol 2011;6:2192-9
16. Ishimori ML, Gudsoorkar V, Venturupalli SR, et al. Disparities in renal replacement in lupus nephritis: current practice and future implications. Arthritis Care Res (Hoboken) 2011;63:1639-41
17. Ward MM, Studenski S. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990;17:220-4 (Pubitemid 20108226)
18. Resende A, Titan S, Barros R, et al. Worse renal outcome of lupus nephritis in male patients: a case-control study. Lupus 2011;20:561-7
19. Chen HA, Wang JJ, Chou CT, et al. Predictors of long term mortality in patients with and without systemic lupus erythematosus on maintenance dialysis: a comparative study. J Rheumatol 2011;38:2390-4
20. Fiehn C, Hajjar Y, Mueller K, et al. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 2003;62:435-9 (Pubitemid 36469735)
21. Esdaile J, Levinton C, Federgreen W, et al. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 1989;72:779-833 (Pubitemid 19230673)
22. Faurschou M, Starklint H, Halberg P, et al. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006;33:1563-9 (Pubitemid 44168828)
23. Korbet SM, Lewis EJ, Schwartz MM, et al. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 2000;35:904-14 (Pubitemid 30238204)
24. Ward MM. Access care incidence end-stage renal disease due systemic lupus erythematosus. J Rheumatol 2010;37:1158-63
25. Krane N, Burjak K, Archie M, et al. Persistent lupus activity in endstage renal disease. Am J Kidney Dis 1999;33:872-9 (Pubitemid 29214683)
26. Bruce IN, Hallett DC, Gladman DD, et al. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy. J Rheumatol 1999;26:1490-4 (Pubitemid 29317870)
27. Okano K, Yumura W, Nitta K, et al. Analysis of lupus activity in endstage renal disease treated by hemodialysis. Intern Med 2001;40:598-602 (Pubitemid 33611892)
28. AI-Hawas F, Abdalla AH, AI-Sulaiman MH, et al. Development of systemic lupus erythematosus in a male patient after 14 years on hemodialysis. Am J Kidney Dis 1997;29:631-2 (Pubitemid 27155289)
29. Barreiro Delgado Y, García Méndez I, Martín Alemany N, et al. Libman-Sacks endocarditis and severe aortic regurgitation in a patient with systemic lupus erythematosus in peritoneal dialysis. Nefrologia 2011;31:619-21
30. Goo YS, Park HC, Choi HY, et al. The evolution of lupus activity among patients with end-stage-renal disease secondary to lupus nephritis. Yonsei Med J 2004;45:199-206 (Pubitemid 38660554)
31. Lee PT, Fang HC, Chen CL, et al. Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus 2003;12:827-32
32. Broder A, Khattri S, Patel R, et al. Undertreatment of disease activity in systemic lupus erythematosus patients with end stage renal failure is associated with increased all-cause mortality. J Rheumatol 2011;38:2382-9
33. Delvin A, Waikar S, Solomon D, et al. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res 2011;63:1642-53
34. Kang SH, Chung BH, Choi SR, et al. Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med 2011; 26:60-7
35. Weng CH, Hsu CW, Yu CC, et al. Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes. Kidney Blood Press Res 2009;32:451-6
36. Siu Y, Leung K, Tong M, et al. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005;20:2797-802 (Pubitemid 41672282)
37. Shafi ST, Gupta M. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis. J Vasc Access 2007;8: 103-8 (Pubitemid 47062119)
38. Naveed A, Nilubol C, Melancon JK, et al. Preemptive kidney transplantation in systemic lupus erythematosus. Transplant Proc 2011;43: 3713-4
39. Liang CC, Huang CC, Wang IK, et al. Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis. Ther Apher Dial 2009;14:35-42
40. Contreras G, Mattiazzi A, Guerra G, et al. Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol 2010;21: 1200-7
41. Lochhead KM, Pirsch JD, D'Alessandro AM, et al. Risk factors for renal allograft loss in patients with systemic lupus erythematosus. Kidney Int 1996;49:512-7 (Pubitemid 26050328)
42. Vaidya S. Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome. Clin Transplant 2012;26:853-6
43. Ward MM. Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis. Kidney Int 2000; 57:2136-43 (Pubitemid 30252308)
44. Norby G, Leivestad T, Mjøen G, et al. Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. Arthritis Rheum 2011;63:733-7
45. Sule S, Fivush B, Neu A, et al. Increased risk of death in pediatric and adult patients with ESKD secondary to lupus. Pediatr Nephrol 2011;26: 93-8.